Cargando…
RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC
The era of precision medicine has resulted in the identification of a number of genomic alterations that can be targeted with novel therapies. In lung adenocarcinomas, a histology structure that accounts for nearly 50% of all cases of lung cancer, and a number of genomic targets have been linked wit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474418/ https://www.ncbi.nlm.nih.gov/pubmed/34589946 http://dx.doi.org/10.1016/j.jtocrr.2020.100050 |